Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes

BACKGROUND: It is unclear if direct-acting oral anticoagulants (DOACs) use before hospitalization due to COVID-19 diagnosis would potentially impact the severity and clinical outcomes thereafter. We compared 30-day hospitalization/re-hospitalization and clinical outcomes between patients on chronic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thromb Res
Autors principals: Rivera-Caravaca, José Miguel, Buckley, Benjamin J.R., Harrison, Stephanie L., Fazio-Eynullayeva, Elnara, Underhill, Paula, Marín, Francisco, Lip, Gregory Y.H.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Ltd. 2021
Matèries:
Full Length Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8236305/
https://ncbi.nlm.nih.gov/pubmed/34218058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2021.06.014
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars